<http://schema.org/description>
"The Institute for Quality and Efficiency in Health Care (IQWiG) assessed current study results on the benefit of a test for human papillomavirus (HPV) and examined whether its first assessment from January 2012 is still valid. The rapid report published by the Institute on 11 June 2014 answers this question with &amp;quot;yes&amp;quot;. IQWiG still sees indications that precursors of cervical cancer can be detected and treated earlier and consequently tumours occur less often in women who underwent this testing."^^<http://www.w3.org/2001/XMLSchema#string>
<http://medicalxpress.com/news/2014-06-hpv-iqwig-indications-benefit-primary.html>